Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Largest group on African continent introduced to Sign Language

2016-07-05

Description: z UFS101 SASL Tags: z UFS101 SASL

The introduction of basic Sign Language
as part of the UFS101 course was a great
success. From left are Susan Lombaard,
Annemarie le Roux, Tshisikhawe Dzivhani
(all from the Department of South African
Sign Language), and Lauren Oosthuizen
(UFS101).
Photo: Leonie Bolleurs

As a result of a new initiative at the University of the Free State (UFS), the largest group of students on the African continent took part in a first-year seminar which included Sign Language.

A total of 5400 students on the Bloemfontein Campus and 1000 on Qwaqwa Campus were taught basic Sign Language by Susan Lombaard, Acting Head of the Department of South African Sign Language, and her team members, Tshisikhawe Dzivhani, Annemarie le Roux, and Nicolene de Klerk.

It forms part of the UFS101 module presented to all first-year students. The initiative, begun in the first semester of 2016, will form part of UFS101 in future and was met with an overwhelmingly positive response.

Three segments of course

Sign Language was taught in three segments and positioned as large-class learning experiences in the Callie Human Centre (Bloemfontein Campus) and the Nelson Mandela Hall (Qwaqwa Campus). Students were taught about deaf culture, Sign Language theory, as well as how to sign their names, exchange pleasantries, and have a basic conversation.

A valuable skill to have

“It (the Sign Language experience) was very interesting and helpful,” said one of the students. “It is important to have the ability to communicate with all sorts of people, and to be able to help them in a crisis”. According to another, it sparked an interest in Sign Language. “It is a skill I will continue to use and try to learn more from it,” said a third.

Lombaard – in collaboration with the UFS101 team – will be presenting a paper related to this achievement at the DeafNet Africa Conference in Johannesburg, from 26 to 30 September 2016.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept